June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Galectin-8-Induced Angiogenesis Is Independent of VEGF-A But Dependent on Integrins
Author Affiliations & Notes
  • Wei-Sheng Chen
    Ophthalmology, Tufts University, Boston, Massachusetts, United States
  • Zhiyi Cao
    Ophthalmology, Tufts University, Boston, Massachusetts, United States
  • Noorjahan A Panjwani
    Ophthalmology, Tufts University, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Wei-Sheng Chen, None; Zhiyi Cao, None; Noorjahan Panjwani, None
  • Footnotes
    Support  R01EY007088 and R01EY009349
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 998. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Wei-Sheng Chen, Zhiyi Cao, Noorjahan A Panjwani; Galectin-8-Induced Angiogenesis Is Independent of VEGF-A But Dependent on Integrins
      . Invest. Ophthalmol. Vis. Sci. 2017;58(8):998.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Galectin-8 is a tandem-repeat type galectin that possesses two different carbohydrate-recognition domains. Our recent study has demonstrated that galectin-8 promotes pathological lymphangiogenesis (the growth of lymphatic vessels) through integrins and podoplanin in the absence of vascular endothelial growth factor receptor-3 (VEGFR-3), the major cell surface receptor that drives lymphangiogenesis. In a separate study, galectin-8 has been shown to promote angiogenesis (the growth of blood vessel). However, it is still elusive whether galectin-8-mediated angiogenesis involves VEGF-A/VEGFR-2 signaling axis, the key angiogenic pathway.

Methods : Human umbilical vein endothelial cell (HUVEC) sprouting assays, corneal micropocket assays, gene knockdown and antibody blocking assays, and galectin-8 knockout mice were used to assess the role and the mechanism of galectin-8-mediated angiogenesis.

Results : In animal models of suture placement and chemical injury in mouse corneas, we showed that inflammatory angiogenesis is markedly reduced in galectin-8 knockout mice. Further, in the corneal micropocket assay, we demonstrated that galectin-8-induced angiogenesis is not affected by VEGF-A blockage. Similarly, in the in vitro 3D sprouting assay by using HUVEC spheroids, galectin-8-induced HUVEC sprouting is not inhibited by a VEGF-A neutralizing antibody. In contrast, blocking antibodies against specific integrins (α5β1, αvβ3 and αvβ5, but not α9β1) markedly attenuated galectin-8-mediated HUVEC sprouting. Using affinity precipitation assays, we demonstrated that galectin-8-associated integrins (α5, αv, β1, β3 and β5) possess complex N-glycans and α2,6-sialyl glycans but not α2,3-sialyl glycans. Moreover, in the in vitro migration assays, we revealed that immobilized galectin-8 promotes HUVEC migration (haptotaxis), whereas soluble galectin-8 has little effect on HUVEC migration (chemotaxis).

Conclusions : Collectively, our results suggest that galectin-8 functions as an extracellular matrix protein to promote angiogenesis. More importantly, integrins but not VEGF-A/VEGFR-2, play a critical role in galectin-8-mediated angiogenesis.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×